Loading...
Loading...
Trademark Dashboard – UK Trademark Search & ClearanceApplication UK00000776729 · Dead
| Application Number | UK00000776729 |
| Status | Dead |
| Owner | Roche Nicholas Ltd |
| Filed | 1958-04-22 |
| Registered | 1958-04-22 |
| Renewal Due | 2007-04-22 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
MYLOMIDE has a current status of Dead.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical preparations for use as hypnotics and as sedatives.
'MYLOMIDE' is a dead trademark on the UK IPO register, owned by Roche Nicholas Ltd. The application (UK00000776729) was filed on 22 April 1958 and registered on 22 April 1958. The registration is set to expire on 22 April 2007.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by Forresters IP LLP.
According to the UK IPO register, 'MYLOMIDE' is owned by Roche Nicholas Ltd.
No — the UK IPO records the status of 'MYLOMIDE' as dead.
'MYLOMIDE' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical preparations for use as hypnotics and as sedatives.
The application for 'MYLOMIDE' was filed on 22 April 1958 and the trademark was registered on 22 April 1958.
The UK IPO first published / advertised 'MYLOMIDE' on 24 September 1958.
The current registration of 'MYLOMIDE' is recorded as valid until 22 April 2007, at which point it will need to be renewed to remain in force.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.